4. Evans HS, Møller H, Robinson D, Lewis CM, Bell CM, Hodgson SV. The risk of subsequent primary cancers after colorectal cancer in southeast England // Gut, 2002; 50(5):647 – 652
5. Gaduputi V, Chandrala C, Tariq H, Kanneganti K. Sign of Leser-Trelat associated with esophageal squamous cell cancer // Case Rep Oncol Med, 2014; 2014:825929
6. Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program // Oncologist, 2007; 12(1):20 – 37
9. Liu L, Zhou C, Zhou L, Peng L, Li D, Zhang X, Zhou M, Kuang P, Yuan Q, Song X, Yang M. Functional FEN1 genetic variants contribute to risk of hepatocellular carcinoma, esophageal cancer, gastric cancer and colorectal cancer // Carcinogenesis, 2012; 33(1): 119 – 123
10. Maida M, Macalusa FS, Galia M, Cabibbo G. Hepatocellular carcinoma and synchronous liver metastases from colorectal cancer in cirrhosis: A case report // World J Hepatol, 2013; 5(12):696 – 700
12. Sun LH, Han HQ, Wang PZ, Tian WJ. Emergency caudate lobectomy for ruptured hepatocellular carcinoma with multiple primary cancers // World J Gastroenterol, 2013; 19(3):418 – 421
13. Sun LC, Tai YY, Liao SM, Lin TY, Shih YL, Chang SF, Huang CW, Chan HM, Huang CJ, Wang JY. Clinical characteristics of second primary cancer in colorectal cancer patients: the impact of colorectal cancer or other second cancer occurring first // World J Surg Oncol, 2014; 12(1):73
14. Ueno M, Muto T, Oya M, Ota H, Azekura K, Yamaguchi T. Multiple primary cancer: an experience at the Cancer Institute Hospital with special reference to colorectal cancer // Int J Clin Oncol, 2003; 8(3):162 – 167